CF PharmTech, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
CF PharmTech, Inc. - overview
Established
2007
Location
Wuxi, Jiangsu, China
Primary Industry
Pharmaceuticals
About
Founded in 2007 and based in Wuxi, China, CF PharmTech, Inc. is a high-tech pharmaceutical company focused on developing pulmonary drug delivery and other drug delivery technologies, targeting domestic and international markets. In October 2025, CF PharmTech, Inc. raised HKD 607.
7 million in an IPO, selling 41. 2 million shares at HKD 14. 75 apiece on the Hong Kong Stock Exchange under the ticker symbol "2652". The company's pipeline covers a full range of respiratory products, addressing high-needs clinical areas such as asthma, chronic obstructive pulmonary disease (COPD) and allergic rhinitis.
The company boasts four R&D and production platforms for inhaled products: metered-dose inhalers (MDIs), dry powder inhalers (DPIs), nebulizers and nasal sprays. The company generates revenue by doing research, development, production and sales of its products and other related services.
Current Investors
CCB International Asset Management, CS Capital, Xin Ding Capital
Primary Industry
Pharmaceuticals
Sub Industries
Medical Devices & Equipment, Pharmaceuticals
Website
www.cfpharmtech.com
Verticals
Manufacturing
Company Stage
Mature
Total Amount Raised
Subscriber access only
CF PharmTech, Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| IPO | Completed | CF PharmTech, Inc. | - | ||||||||
| Series F | Completed | CF PharmTech, Inc. | - | ||||||||
| Series E | Completed | CF PharmTech, Inc. | - | ||||||||
| Series D | Completed | CF PharmTech, Inc. | - | ||||||||
| Series C | Completed | CF PharmTech, Inc. | - |
Displaying 1 - 5 of 7
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.